NCT01703845View on ClinicalTrials.gov

A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium (high dose) + Olodaterol

Tiotropium + Olodaterol solution for inhalation

DRUG

Tiotropium (low dose) + Olodaterol

Tiotropium + Olodaterol solution for inhalation

Trial Locations (1)

Unknown

1237.24.24001 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY